Identification of cancer stem cell markers in human malignant mesothelioma cells

Farhana Ishrat Ghani, Hiroto Yamazaki, Satoshi Iwata, Toshihiro Okamoto, Keisuke Aoe, Kazunori Okabe, Yusuke Mimura, Nobukazu Fujimoto, Takumi Kishimoto, Taketo Yamada, C. Wilson Xu, Chikao Morimoto

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Malignant mesothelioma (MM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells and usually associated with long-term asbestos exposure. Recent studies suggest that tumors contain cancer stem cells (CSCs) and their stem cell characteristics are thought to confer therapy-resistance. However, whether MM cell has any stem cell characteristics is not known. To understand the molecular basis of MM, we first performed serial transplantation of surgical samples into NOD/SCID mice and established new cell lines. Next, we performed marker analysis of the MM cell lines and found that many of them contain SP cells and expressed several putative CSC markers such as CD9, CD24, and CD26. Interestingly, expression of CD26 closely correlated with that of CD24 in some cases. Sorting and culture assay revealed that SP and CD24+ cells proliferated by asymmetric cell division-like manner. In addition, CD9+ and CD24+ cells have higher potential to generate spheroid colony than negative cells in the stem cell medium. Moreover, these marker-positive cells have clear tendency to generate larger tumors in mouse transplantation assay. Taken together, our data suggest that SP, CD9, CD24, and CD26 are CSC markers of MM and could be used as novel therapeutic targets.

Original languageEnglish
Pages (from-to)735-742
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume404
Issue number2
DOIs
Publication statusPublished - 2011 Jan 14

Fingerprint

Neoplastic Stem Cells
Stem cells
Cells
Stem Cells
Tumors
Assays
Pleural Neoplasms
Transplantation
Asymmetric Cell Division
Asbestos
Cell Line
Inbred NOD Mouse
SCID Mice
Sorting
Malignant Mesothelioma
Neoplasms
Therapeutics

Keywords

  • Cancer stem cells
  • CD24
  • CD26
  • CD9
  • Malignant mesothelioma
  • Side population

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Ghani, F. I., Yamazaki, H., Iwata, S., Okamoto, T., Aoe, K., Okabe, K., ... Morimoto, C. (2011). Identification of cancer stem cell markers in human malignant mesothelioma cells. Biochemical and Biophysical Research Communications, 404(2), 735-742. https://doi.org/10.1016/j.bbrc.2010.12.054

Identification of cancer stem cell markers in human malignant mesothelioma cells. / Ghani, Farhana Ishrat; Yamazaki, Hiroto; Iwata, Satoshi; Okamoto, Toshihiro; Aoe, Keisuke; Okabe, Kazunori; Mimura, Yusuke; Fujimoto, Nobukazu; Kishimoto, Takumi; Yamada, Taketo; Xu, C. Wilson; Morimoto, Chikao.

In: Biochemical and Biophysical Research Communications, Vol. 404, No. 2, 14.01.2011, p. 735-742.

Research output: Contribution to journalArticle

Ghani, FI, Yamazaki, H, Iwata, S, Okamoto, T, Aoe, K, Okabe, K, Mimura, Y, Fujimoto, N, Kishimoto, T, Yamada, T, Xu, CW & Morimoto, C 2011, 'Identification of cancer stem cell markers in human malignant mesothelioma cells', Biochemical and Biophysical Research Communications, vol. 404, no. 2, pp. 735-742. https://doi.org/10.1016/j.bbrc.2010.12.054
Ghani, Farhana Ishrat ; Yamazaki, Hiroto ; Iwata, Satoshi ; Okamoto, Toshihiro ; Aoe, Keisuke ; Okabe, Kazunori ; Mimura, Yusuke ; Fujimoto, Nobukazu ; Kishimoto, Takumi ; Yamada, Taketo ; Xu, C. Wilson ; Morimoto, Chikao. / Identification of cancer stem cell markers in human malignant mesothelioma cells. In: Biochemical and Biophysical Research Communications. 2011 ; Vol. 404, No. 2. pp. 735-742.
@article{49f9c0ce4ca2485aa829dc8df93f8370,
title = "Identification of cancer stem cell markers in human malignant mesothelioma cells",
abstract = "Malignant mesothelioma (MM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells and usually associated with long-term asbestos exposure. Recent studies suggest that tumors contain cancer stem cells (CSCs) and their stem cell characteristics are thought to confer therapy-resistance. However, whether MM cell has any stem cell characteristics is not known. To understand the molecular basis of MM, we first performed serial transplantation of surgical samples into NOD/SCID mice and established new cell lines. Next, we performed marker analysis of the MM cell lines and found that many of them contain SP cells and expressed several putative CSC markers such as CD9, CD24, and CD26. Interestingly, expression of CD26 closely correlated with that of CD24 in some cases. Sorting and culture assay revealed that SP and CD24+ cells proliferated by asymmetric cell division-like manner. In addition, CD9+ and CD24+ cells have higher potential to generate spheroid colony than negative cells in the stem cell medium. Moreover, these marker-positive cells have clear tendency to generate larger tumors in mouse transplantation assay. Taken together, our data suggest that SP, CD9, CD24, and CD26 are CSC markers of MM and could be used as novel therapeutic targets.",
keywords = "Cancer stem cells, CD24, CD26, CD9, Malignant mesothelioma, Side population",
author = "Ghani, {Farhana Ishrat} and Hiroto Yamazaki and Satoshi Iwata and Toshihiro Okamoto and Keisuke Aoe and Kazunori Okabe and Yusuke Mimura and Nobukazu Fujimoto and Takumi Kishimoto and Taketo Yamada and Xu, {C. Wilson} and Chikao Morimoto",
year = "2011",
month = "1",
day = "14",
doi = "10.1016/j.bbrc.2010.12.054",
language = "English",
volume = "404",
pages = "735--742",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Identification of cancer stem cell markers in human malignant mesothelioma cells

AU - Ghani, Farhana Ishrat

AU - Yamazaki, Hiroto

AU - Iwata, Satoshi

AU - Okamoto, Toshihiro

AU - Aoe, Keisuke

AU - Okabe, Kazunori

AU - Mimura, Yusuke

AU - Fujimoto, Nobukazu

AU - Kishimoto, Takumi

AU - Yamada, Taketo

AU - Xu, C. Wilson

AU - Morimoto, Chikao

PY - 2011/1/14

Y1 - 2011/1/14

N2 - Malignant mesothelioma (MM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells and usually associated with long-term asbestos exposure. Recent studies suggest that tumors contain cancer stem cells (CSCs) and their stem cell characteristics are thought to confer therapy-resistance. However, whether MM cell has any stem cell characteristics is not known. To understand the molecular basis of MM, we first performed serial transplantation of surgical samples into NOD/SCID mice and established new cell lines. Next, we performed marker analysis of the MM cell lines and found that many of them contain SP cells and expressed several putative CSC markers such as CD9, CD24, and CD26. Interestingly, expression of CD26 closely correlated with that of CD24 in some cases. Sorting and culture assay revealed that SP and CD24+ cells proliferated by asymmetric cell division-like manner. In addition, CD9+ and CD24+ cells have higher potential to generate spheroid colony than negative cells in the stem cell medium. Moreover, these marker-positive cells have clear tendency to generate larger tumors in mouse transplantation assay. Taken together, our data suggest that SP, CD9, CD24, and CD26 are CSC markers of MM and could be used as novel therapeutic targets.

AB - Malignant mesothelioma (MM) is an aggressive and therapy-resistant neoplasm arising from the pleural mesothelial cells and usually associated with long-term asbestos exposure. Recent studies suggest that tumors contain cancer stem cells (CSCs) and their stem cell characteristics are thought to confer therapy-resistance. However, whether MM cell has any stem cell characteristics is not known. To understand the molecular basis of MM, we first performed serial transplantation of surgical samples into NOD/SCID mice and established new cell lines. Next, we performed marker analysis of the MM cell lines and found that many of them contain SP cells and expressed several putative CSC markers such as CD9, CD24, and CD26. Interestingly, expression of CD26 closely correlated with that of CD24 in some cases. Sorting and culture assay revealed that SP and CD24+ cells proliferated by asymmetric cell division-like manner. In addition, CD9+ and CD24+ cells have higher potential to generate spheroid colony than negative cells in the stem cell medium. Moreover, these marker-positive cells have clear tendency to generate larger tumors in mouse transplantation assay. Taken together, our data suggest that SP, CD9, CD24, and CD26 are CSC markers of MM and could be used as novel therapeutic targets.

KW - Cancer stem cells

KW - CD24

KW - CD26

KW - CD9

KW - Malignant mesothelioma

KW - Side population

UR - http://www.scopus.com/inward/record.url?scp=78651367358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651367358&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.12.054

DO - 10.1016/j.bbrc.2010.12.054

M3 - Article

C2 - 21163253

AN - SCOPUS:78651367358

VL - 404

SP - 735

EP - 742

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -